Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-03-26

Clinical Trial Update: Study Testing Ketamine Sublingual Wafer After Wisdom Tooth Extraction [Phase 2]

View source ↗

Summary

Phase 2 study evaluating a ketamine sublingual wafer for postoperative dental pain after wisdom tooth extraction has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketamine Sublingual Wafer (ketamine)

Snippet

Sponsor: iX Biopharma Ltd. | Conditions: Pain | Phase 2 | Status: COMPLETED